Skip to main content
. 2022 Dec 14;13:1032822. doi: 10.3389/fendo.2022.1032822

Table 1.

Characteristics for the investigated patient groups. Below is shown identification number related to DiViD and nPOD repositories of analyzed samples.

n (M/F) Age BMI Diabetes duration C-peptide
Controls 18 (9/9) 35.5 [14.2-68] 25.1 [14.9-35.1] 2.9 [0.5-17.9]
T1D Long term T1D 20 (10/10) 19 [5-43.5] 24.6 [11,9-30.9] 5 [0-21] y 0.05 [0.05-0.48]
Ab Antibody positive 12 (7/5) 38.5 [4.3-69.2] 25.4 [14.8-34.3] 5.4 [0.06-26.2]
T2D Type 2 diabetes 8 (3/5) 43.9 [18.8-62] 35.7 [19.9-41] 2 [0-15] y 3.5 [0.58-10.7]
Dx T1D at diagnosis 5 (3/2) 31 [24-35] 25.6 [20,9-28.6] NA
Tx Transplanted, recurrent 4 (3/1) 44.5 [38-63] 23.9 [22.7-26] NA

Controls 6013, 6024, 6048, 6075, 6012, 6099, 6140, 6162, 6168, 6227, 6129, 6165, 6102, 6229, 6251, 6010, 6179, 6019

T1D 6070, 6084, 6088, 6180, 6224, 6243, 6228, 6209, 6038, 6046, 6069, 6195, 6052, 6268, 6265, 6196, 6211, 6113, 6264, 6135

Ab 6080, 6123, 6158, 6167, 6171, 6044, 6101, 6154, 6156, 6181, 6197, 6147

T2D 6188, 6114, 6249, 6275, 6273, 6191, 6059, 6110

Dx DiViD-6, DiViD-5, DiViD-4, DiViD-3, DiViD-2

Tx 3678-01, 3681-02, 3717-01, 3626-D